"Cell Line, Transformed" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.
| Descriptor ID |
D002461
|
| MeSH Number(s) |
A11.251.210.172
|
| Concept/Terms |
Cell Line, Transformed- Cell Line, Transformed
- Transformed Cell Line
- Cell Lines, Transformed
- Transformed Cell Lines
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Transformed".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Transformed".
This graph shows the total number of publications written about "Cell Line, Transformed" by people in this website by year, and whether "Cell Line, Transformed" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Transformed" by people in Profiles.
-
Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica. 2015 Sep; 100(9):1189-98.
-
H2O2-dependent translocation of TCTP into the nucleus enables its interaction with VDR in human keratinocytes: TCTP as a further module in calcitriol signalling. J Steroid Biochem Mol Biol. 2010 Jan; 118(1-2):29-40.
-
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis. 2007 Feb; 25(2):401-11.
-
Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide. Biochem Pharmacol. 1998 May 01; 55(9):1523-9.
MeSH information
